VINCRISTINE Safety Questions, VINCRISTINE Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about VINCRISTINE. Our extensive database of VINCRISTINE adverse events and VINCRISTINE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about VINCRISTINE
VINCRISTINE Safety Reports
Total VINCRISTINE reports: 115.VINCRISTINE FDA safety alerts: No.
Reported deaths: 32 Reported hospitalizations: 40.
Take VINCRISTINE Side Effects Survey or Share Your VINCRISTINE Story. Read More Here.
Showing 1-75 of 115 Next >
Physician from UNITED STATES reported VINCRISTINE problem on Oct 16, 2006. Female patient, 18 years of age, was diagnosed with neuroectodermal neoplasm and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: csf test abnormal, faecal incontinence, herpes zoster, myelitis, sensory disturbance, spinal cord disorder, urinary incontinence. VINCRISTINE dosage: 1.5 MG/M2, 2 CYCLES A MONTH, DAY 0. During the same period patient was treated with CARBOPLATIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, GRANULOCYTE COLONY STIMULATING FACTOR, THIOTEPA, ACYCLOVIR. Patient recovered.VINCRISTINE problem was reported by a Physician from UNITED STATES on Oct 16, 2006. Male patient, child 5 years of age, was diagnosed with neuroectodermal neoplasm and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: faecal incontinence, gait disturbance, muscular weakness, myelitis transverse, nervous system disorder, paraplegia, urinary incontinence. VINCRISTINE dosage: 1.5 MG/M2, 2 CYCLE A MONTH, DAY 0, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, GRANULOCYTE SIMULATING FACTORS, THIOTEPA. Patient recovered.
Health Professional from UNITED STATES reported VINCRISTINE problem on Oct 23, 2006. Male patient, child 5 years of age, was diagnosed with primitive neuroectodermal tumour and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: myelitis, myelitis transverse. VINCRISTINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, CARBOPLATIN, ETOPOSIDE, THIOTEPA, GRANULOCYTE CSF, HEMATOPOETIC PROGENITOR CELLS. Patient recovered.
VINCRISTINE problem was reported by a Physician from GERMANY on Aug 03, 2006. Female patient, 66 years of age, weighting 187.4 lb, was diagnosed with multiple myeloma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: dental treatment, device failure, oral surgery, osteonecrosis. VINCRISTINE dosage: unknown. During the same period patient was treated with MELPHALAN, ZOMETA. Patient recovered.
Health Professional from UNITED KINGDOM reported VINCRISTINE problem on Oct 27, 2006. Male patient, 50 years of age, weighting 183.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: hypoacusis, tinnitus. VINCRISTINE dosage: 2 MG Q3W IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISOLONE, RITUXIMAB. Patient recovered.
VINCRISTINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 27, 2006. Female patient, 25 years of age, was diagnosed with sarcoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: infertility female. VINCRISTINE dosage: unknown. Patient recovered.
Physician from GERMANY reported VINCRISTINE problem on Dec 01, 2006. Male patient, 48 years of age, was diagnosed with multiple myeloma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: anaemia, meningitis listeria, paresis cranial nerve. VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE, AMPICILLIN. Patient was hospitalized. Patient recovered.
VINCRISTINE problem was reported by a Consumer or non-health professional from MEXICO on Dec 08, 2006. Female patient, 73 years of age, weighting 121.3 lb, was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, blood albumin decreased, blood calcium decreased, blood magnesium decreased, blood potassium decreased, dehydration, escherichia infection, gastroenteritis, haemoglobin decreased. VINCRISTINE dosage: 1.4 MG/M2 Q3W IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, LOPERAMIDE, CIPROFLOXACIN, ACETAMINOPHEN, FOLIC ACID, CALCIUM CASENAT, CIANOCOBALAMIN, FILGRASTIM. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from MEXICO reported VINCRISTINE problem on Dec 08, 2006. Female patient, 52 years of age, weighting 189.6 lb, was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: bone pain, cervical spine flattening, intervertebral disc protrusion, intervertebral discitis, musculoskeletal pain, myalgia, pain in extremity. VINCRISTINE dosage: 2 MG Q3W IV. Patient was hospitalized. Patient recovered.
VINCRISTINE problem was reported by a Consumer or non-health professional from MEXICO on Dec 08, 2006. Female patient, 73 years of age, weighting 121.3 lb, was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal pain, blood calcium decreased, blood potassium decreased, dehydration, diarrhoea, febrile neutropenia, gastroenteritis, hyperchloraemia. VINCRISTINE dosage: 1.4 MG/M2 Q3W IV. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
Physician from UNITED KINGDOM reported VINCRISTINE problem on Dec 14, 2006. Male patient, 13 years of age, was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: nerve conduction studies, peripheral motor neuropathy. VINCRISTINE dosage: unknown. Patient recovered.
VINCRISTINE problem was reported by a Physician from UNITED KINGDOM on Dec 14, 2006. Male patient, 13 years of age, was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: duodenal perforation, neuropathy, oesophageal perforation. VINCRISTINE dosage: unknown. Patient recovered.
Physician from UNITED KINGDOM reported VINCRISTINE problem on Dec 14, 2006. Female patient, child 2 years of age, was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: intestinal perforation, sepsis. VINCRISTINE dosage: unknown. Patient recovered.
VINCRISTINE problem was reported by a Physician from UNITED STATES on July 06, 2007. Male patient, 17 years of age, was diagnosed with b-cell type acute leukaemia, analgesia and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: ascites, bacterial infection, dialysis, diverticular perforation, escherichia infection, ileus, mucosal inflammation, neutropenia, pneumoperitoneum. VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE, POLYETHYLENE GLYCOL, OPIATES, RANITIDINE, MAXIPIME, TOBRAMYCIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from ITALY reported VINCRISTINE problem on July 03, 2007. Female patient, 50 years of age, was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome, toxic epidermal necrolysis. VINCRISTINE dosage: unknown. Patient was hospitalized. Patient recovered.
VINCRISTINE problem was reported by a Health Professional from UNITED STATES on July 16, 2007. Male patient, 43 years of age, was diagnosed with follicle centre lymphoma, follicular grade i, ii, iii stage iv and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, treatment related secondary malignancy. VINCRISTINE dosage: 1.4 MG/M2 PER_CYCLE IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISONE, TOSITUMOMAB. Patient recovered.
Consumer or non-health professional from UNITED STATES reported VINCRISTINE problem on July 27, 2007. Male patient, weighting 179.0 lb, was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: asthenia, emphysema, fatigue, lobar pneumonia, lung disorder, pneumothorax, procedural complication, pulmonary mass. VINCRISTINE dosage: 2 MG. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.
VINCRISTINE problem was reported by a Physician from ITALY on July 16, 2007. Male patient, 51 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: bedridden, dysphagia, guillain-barre syndrome, muscular weakness, paraesthesia, respiratory failure. VINCRISTINE dosage: 1.4 MG/M2 FREQ. During the same period patient was treated with METHYLPREDNISOLONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, RITUXAN. Patient recovered.
Health Professional from TURKEY reported VINCRISTINE problem on July 22, 2007. Male patient, 69 years of age, was diagnosed with hodgkin's disease and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: haemodynamic instability, haemoglobin decreased, lower gastrointestinal haemorrhage, platelet count decreased. VINCRISTINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE. Patient recovered.
VINCRISTINE problem was reported by a Consumer or non-health professional from FRANCE on July 17, 2007. Male patient was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: antithrombin iii decreased, pancreatitis. VINCRISTINE dosage: 2 MG WEEKLY IV. During the same period patient was treated with KIDROLASE, ZAVEDOS, CORTANCYL MFR, ATARAX, ANTALVIC, TOPALGIC, METHOTREXATE. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported VINCRISTINE problem on July 27, 2007. Male patient, 16 years of age, was diagnosed with retinoblastoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, sepsis. VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE. Patient died.
VINCRISTINE problem was reported by a Health Professional from UNITED STATES on July 30, 2007. Female patient, 16 years of age, was diagnosed with ewing's sarcoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: mucoepidermoid carcinoma. VINCRISTINE dosage: 1.5 MG/M2. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE, DACTINOMYCIN. Patient recovered.
Consumer or non-health professional from FRANCE reported VINCRISTINE problem on July 27, 2007. Female patient, 70 years of age, was diagnosed with ewing's sarcoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: encephalopathy, hyponatraemia, oliguria, somnolence. VINCRISTINE dosage: unknown. During the same period patient was treated with HOLOXAN, ADRIAMYCIN PFS, CARDIOXANE, ZOFRAN. Patient was hospitalized. Patient recovered.
VINCRISTINE problem was reported by a Physician from NETHERLANDS on July 31, 2007. Female patient, 50 years of age, was diagnosed with multiple myeloma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: laryngeal oedema, respiratory failure, stem cell transplant, stomatitis. VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE, THALIDOMIDE, MELPHALAN, POTASSIUM CHLORIDE, PRIMPERAN. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported VINCRISTINE problem on July 31, 2007. Male patient, child 9 years of age, was diagnosed with t-cell type acute leukaemia and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, brain oedema, constipation, convulsion, coordination abnormal, delirium, gliosis, hypertension. VINCRISTINE dosage: unknown. During the same period patient was treated with CYTARABINE, METHOTREXATE, PREDNISONE, DOXORUBICIN. Patient recovered.
VINCRISTINE problem was reported by a Pharmacist from UNITED STATES on Aug 15, 2007. Male patient, 53 years of age, was diagnosed with b-cell lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: b-cell lymphoma, diabetic neuropathy. VINCRISTINE dosage: unknown. During the same period patient was treated with HUMALOG, WELLBUTRIN, TRAZODONE, NORVASC, LOPRESSOR, ZESTRIL, FOLIC ACID. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from ITALY reported VINCRISTINE problem on Aug 07, 2007. Female patient, child 12 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: blood osmolarity decreased, cholelithiasis, hepatomegaly, hyponatraemia, pancreatitis acute. VINCRISTINE dosage: 2.5 MG (1 MG/ML- CYCLICAL); INTRAVENOUS (NO OTHERWISE SPECIFIED). During the same period patient was treated with ASPARAGINASE, PREDNISONE, DAUNORUBICIN, METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.
VINCRISTINE problem was reported by a Physician from GERMANY on Aug 07, 2007. Male patient, child 10 years of age, was diagnosed with fibromatosis and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, fall, gait disturbance, peripheral sensorimotor neuropathy, transaminases increased. VINCRISTINE dosage: 2 MG 1 IN 1 WK INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient was hospitalized. Patient recovered.
Health Professional from KOREA, REPUBLIC OF reported VINCRISTINE problem on Aug 20, 2007. Male patient, child 9 years of age, was diagnosed with brain neoplasm, convulsion, caecitis and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: colonic pseudo-obstruction, pancytopenia. VINCRISTINE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN, CARBOPLATIN, VALPROIC ACID, PHENYTOIN, TOPIRAMATE, CLONAZEPAM, ANTIBIOTICS. Patient recovered.
VINCRISTINE problem was reported by a Physician from GERMANY on Aug 07, 2007. Male patient, child 10 years of age, was diagnosed with fibromatosis and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: abasia, coordination abnormal, fall, peripheral motor neuropathy, peripheral sensory neuropathy, transaminases increased. VINCRISTINE dosage: 2 MG WEEKLY IV. Patient was hospitalized. Patient recovered.
Health Professional from KOREA, REPUBLIC OF reported VINCRISTINE problem on Aug 22, 2007. Male patient, child 9 years of age, was diagnosed with brain neoplasm, convulsion, caecitis and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: caecitis, colonic pseudo-obstruction, convulsion, pancytopenia, pseudomembranous colitis. VINCRISTINE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN, CARBOPLATIN, VALPROIC ACID, PHENYTOIN, TOPIRAMATE, CLONAZEPAM, ANTIBIOTICS. Patient recovered.
VINCRISTINE problem was reported by a Consumer or non-health professional from FRANCE on Aug 13, 2007. Male patient, 61 years of age, was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: brain herniation, endocarditis staphylococcal, ischaemic stroke, lung abscess, sepsis, septic embolus. VINCRISTINE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, DOXORUBICIN. Patient died on 06/29/2007.
Consumer or non-health professional from KOREA, REPUBLIC OF reported VINCRISTINE problem on Aug 15, 2007. Male patient, child 9 years of age, was diagnosed with brain neoplasm and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: colonic pseudo-obstruction, ileus, pancytopenia. VINCRISTINE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN, CARBOPLATIN, VALPROIC ACID, PHENYTOIN, TOPIRAMATE, CLONAZEPAM. Patient was hospitalized. Patient recovered.
VINCRISTINE problem was reported by a Physician from KOREA, REPUBLIC OF on Aug 13, 2007. Female patient, child 9 years of age, was diagnosed with medulloblastoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: caecitis, colonic pseudo-obstruction, convulsion, pancytopenia, pseudomembranous colitis. VINCRISTINE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN, CARBOPLATIN, CLONAZEPAM. Patient was hospitalized. Patient recovered.
Health Professional from DENMARK reported VINCRISTINE problem on Aug 31, 2007. Female patient, child 3 years of age, was diagnosed with b precursor type acute leukaemia and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: dysphagia, mucous membrane disorder, oesophageal disorder, oesophageal stenosis. VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN, METHOTREXATE, PREDNISOLONE, MICONAZOLE, TAZOBACTAM, GENTAMICIN, FLUCONAZOLE DATES, CEFTAZIDIME. Patient recovered.
VINCRISTINE problem was reported by a Physician from ITALY on Aug 31, 2007. Male patient, 51 years of age, was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: bedridden, condition aggravated, csf protein increased, dysphagia, guillain-barre syndrome, lymphocyte count decreased, white blood cell count decreased. VINCRISTINE dosage: (1.4 MG/M2). During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, METHYLPREDNISOLONE, RITUXIMAB. Patient recovered.
Physician from TURKEY reported VINCRISTINE problem on Sept 10, 2007. Male patient, child 4 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, cranial neuropathy, neuropathy peripheral. VINCRISTINE dosage: 1.5 MG/M2 FREQ. During the same period patient was treated with ANTRHACYCLINE. Patient recovered.
VINCRISTINE problem was reported by a Health Professional from SPAIN on Sept 25, 2007. Male patient, 19 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: lung infection pseudomonal, malignant neoplasm progression, neurotoxicity. VINCRISTINE dosage: 2 MG ON DAY 1 AND 8.. During the same period patient was treated with METHOTREXATE, HYDROCORTISONE SUCCINATE, DAUNORUBICIN, PREDNISONE, CYTARABINE, DEXAMETHASONE. Patient died.
Health Professional from UNITED STATES reported VINCRISTINE problem on Sept 12, 2007. Female patient, 73 years of age, was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: granulocytopenia. VINCRISTINE dosage: unknown. During the same period patient was treated with CYTOXAN, CLOZAPINE. Patient recovered.
VINCRISTINE problem was reported by a Health Professional from TURKEY on Sept 23, 2007. Male patient, 20 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: bone marrow necrosis, escherichia infection, febrile neutropenia, osteonecrosis, sepsis. VINCRISTINE dosage: 1 MG PER_CYCLE. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, DEXAMETHASONE. Patient died.
Showing 1-75 of 115 Next >
This
drug has an active FDA Safety Alert